cytarabine and hydroxychloroquine

cytarabine has been researched along with hydroxychloroquine in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Cheong, JW; Eom, JI; Jang, JE; Jeung, HK; Kim, JS; Kim, Y; Kim, YS; Min, YH1
Cheong, JW; Eom, JI; Jeung, HK; Kim, Y; Min, YH1
Angelov, D; Cotter, AG; Fay, M; Lambert, JS; McGettrick, P; McGinty, T; O'Kelly, B; Sheehan, G1

Reviews

1 review(s) available for cytarabine and hydroxychloroquine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

3 other study(ies) available for cytarabine and hydroxychloroquine

ArticleYear
Induction of cytosine arabinoside-resistant human myeloid leukemia cell death through autophagy regulation by hydroxychloroquine.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2015, Volume: 73

    Topics: Antimetabolites, Antineoplastic; Autophagy; Cell Death; Cytarabine; Drug Resistance, Neoplasm; Humans; Hydroxychloroquine; Leukemia, Myeloid, Acute; U937 Cells

2015
Enhanced autophagy in cytarabine arabinoside-resistant U937 leukemia cells and its potential as a target for overcoming resistance.
    Molecular medicine reports, 2016, Volume: 13, Issue:4

    Topics: Antimetabolites, Antineoplastic; Autophagy; Blotting, Western; Cytarabine; Drug Resistance, Neoplasm; Genes, Reporter; Green Fluorescent Proteins; Humans; Hydroxychloroquine; Leukemia, Myeloid, Acute; Microscopy, Electron, Transmission; Microscopy, Fluorescence; Microtubule-Associated Proteins; U937 Cells

2016
Outcome of a patient with refractory Hodgkin lymphoma on pembrolizumab, infected with SARS-CoV-2.
    British journal of haematology, 2020, Volume: 190, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Betacoronavirus; Bleomycin; Coronavirus Infections; COVID-19; Cyclophosphamide; Cytarabine; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Hydroxychloroquine; Idarubicin; Mediastinal Neoplasms; Pandemics; Pneumonia, Viral; Positron-Emission Tomography; Prednisone; Procarbazine; SARS-CoV-2; Treatment Outcome; Vinblastine; Vincristine

2020